1. . 2014. Comprehensive molecular profiling of lung adenocarcinoma. In Nature, 511, 543-50. doi:10.1038/nature13385. https://pubmed.ncbi.nlm.nih.gov/25079552/
2. Machour, Feras E, R Abu-Zhayia, Enas, Kamar, Joyce, Simon, Itamar, Ayoub, Nabieh. 2024. Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma. In Nature communications, 15, 6417. doi:10.1038/s41467-024-50882-0. https://pubmed.ncbi.nlm.nih.gov/39080280/
3. Chang, Jiang, Zhang, Yaodong, Zhou, Tao, Li, Changxian, Li, Xiangcheng. 2024. RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma. In Journal of experimental & clinical cancer research : CR, 43, 104. doi:10.1186/s13046-024-03030-x. https://pubmed.ncbi.nlm.nih.gov/38576051/
4. Giannakis, Marios, Mu, Xinmeng Jasmine, Shukla, Sachet A, Ogino, Shuji, Garraway, Levi A. 2016. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. In Cell reports, 15, 857-865. doi:10.1016/j.celrep.2016.03.075. https://pubmed.ncbi.nlm.nih.gov/27149842/
5. Guo, Linwei, Wang, Yunjin, Yang, Wenxiao, Hu, Xin, Xu, Ye. 2023. Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis. In Gastroenterology, 165, 414-428.e7. doi:10.1053/j.gastro.2023.04.029. https://pubmed.ncbi.nlm.nih.gov/37146911/
6. Bao, Yufang, Zhang, Sirui, Zhang, Xiaoyu, Wang, Zefeng, Wang, Yongbo. . RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition. In Cancer research, 83, 1490-1502. doi:10.1158/0008-5472.CAN-22-1549. https://pubmed.ncbi.nlm.nih.gov/36853175/
智鼠故事 
